Annual Report

Overview

The report presents the Group's 2023 performance across specialty pharmacy, physician research assistance and health insurance services, with consolidated revenue of RMB'000 4,712,107. It describes the first ESG materiality assessment, Board oversight and an ESG Working Group. Environmental KPIs include Scope 1 emissions of 12.79 and Scope 2 emissions of 1247.27 tonnes of CO2 equivalent, while social disclosures include 3,096 employees, 19,162.6 total training hours and zero work-related fatalities. The report also highlights healthcare-access initiatives including Hui Min Insurance and collaborations intended to improve access to medicines.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 19 March 2024
Language: English, Chinese
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services